Plasma immunoreactive leptin and neuropeptide Y levels in kidney transplant patients

American Journal of Nephrology

Volumn 19, Issue 1, 1999, Pages 28-33

  Kokot, Franciszek ^a,c   Adamczak, Marcin ^a   Wiȩcek, Andrzej ^a   Spiechowicz, Urszula ^a   Mesjasz, Jacek ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Division of Nephrology   (Poland)

^c Dept Nephrology Endocrinol M   (Poland)

Author keywords

Chronic renal failure; Kidney transplantation; Leptin; Neuropeptide Y

Indexed keywords

LEPTIN; NEUROPEPTIDE Y;

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033034583     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013421     Document Type: Article

References (32)

1. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 1996;50:343-357.
2. Hylander B, Barkeling B, Rössner S: Changes in patients' eating behaviour: In the uraemic state, on continous ambulatory peritoneal dialysis treatment and after transplantation. Am J Kidney Dis 1997;29:691-698.
3. Zhang Y, Proenca R, Maffei M, Barone M, Lori L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
4. Bray GA: Leptin and leptinomania. Lancet 1996;348:140-141.
5. Dryden S, Williams G: Leptin as a neuromodulator of feeding and energy balance. Curr Opin Endocrinol Diabetes 1997;4:127-129.
6. Lönnquist F, Schalling M: Role of leptin and its receptor in human obesity. Curr Opin Endocrinol Diabetes 1997;4:164-171.
7. Kalra SP, Kalra PS: Is neuropeptide Y a naturally occurring appetite transducer? Curr Opin Endocrinol Diabetes 1996;3:157-163.
8. Dryden S, Frankish H, Wang O, Williams G: Neuropeptide Y and energy balance: One way ahead for the treatment of obesity? Eur J Clin Invest 1994;24:293-308.
9. Schwarz MW, Seeley RJ: Neuroendocrine responses to starvation and weight loss. N Engl J Med 1997;336:1802-1811.
10. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BRC, Kurnik PB, O'Connor J, Sinha M, Caro JF: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997;51: 1980-1985.
11. Stenvinkel P, Heimbürger O, Lönnqvist F: Serum leptin concentration correlates to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 1997;12:1321-1325.
12. Heimbürger O, Lönnquist F, Danielsson A, Nordenström J, Stenvinkel P: Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:1423-1430.
13. Kokot F, Wiȩcek A, Mesjasz J, Adamczak M, Spiechowicz U: Influence of long-term recombinant human erythropoietin (rHuEPO) therapy on plasma leptin and neuropeptide Y concentration in haemodialyzed uraemic patients. Nephrol Dial Transplant 1998;13:1200-1205.
14. Merabet E, Dagogo JS, Coyne W, Klein S, Santiago JV, Hmiel P, Landt M: Increased leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997;82:847-850.
15. Vos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958-15961.
16. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tonquist H, Hauner H: Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996;45:1435-1438.
17. Yoshida T, Hayashi M, Monkawa T, Saruta T: Regulation of obese mRNA expression by hormonal factors in primary cultures of rat adipocytes. Eur J Endocrinol 1996;135:619-625.
18. Larsson H, Ahren B: Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996; 81:4428-4432.
19. White BD, Dean RG, Martin RJ : Adrenalectomy decreases neuropeptide Y mRNA levels in arcuate nucleus. Brain Res Bull 1990;25:711-715.
20. Higuchi H, Yang H-YT, Sabol SL: Rat neuropeptide Y precursor gene expression, mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP and phorbol ester. J Biol Chem 1988;263:6288-6295.
21. Klein S, Coppack SW, Mohamed-Ali V, Landt M: Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996; 45:984-987.
22. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
23. Kokot F, Ulman I, Wiȩcek A, Irzyniec T, Ulman J: Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis. Arch Immunol Ther Exp 1998;46:311-316.
24. Alvestrand A, Mujagic M, Wajngot A, Efendic S: Glucose intolerance in uraemic patients: The relative contributions of impaired β-cell function and insulin resistance. Clin Nephrol 1989; 31:175-183.
25. Grünfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR: Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 1996; 97:2152-2157.
26. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ, Flier JS, Lowell BB, Fraker DL, Alexander HR: Multiple cytokines and acute inflammation raise mouse leptin levels. Potential role in inflammatory anorexia. J Exp Med 1997;185:171-175.
27. Pereira BJG. Poutsiaka DD, King AJ, Strom AJ, Narayan G, Levey AS, Dinarello CA: In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 1992;42:1419-1424.
28. Ghysen J, De Plaen JI, van Ypersele de Strihou C: The effect of membrane characteristics on tumor necrosis factor kinetics during haemodialysis. Nephrol Dial Transplant 1990;5:270-274.
29. Caro J, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentatova I, Goldman WH, Lynn RB, Zhang P-L, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serurn leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 1996;348:159-161.
30. Viidas U, Noree LO, Aklmen J: Ambulatory 24-hour blood pressure and peptide balance in hemodialysis patients. Scand J Urol Nephrol 1995;29:259-263.
31. Hengbrant J, Thysell H, Ekman R: Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment. Scand J Urol Nephrol 1992;26:169-176.
32. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, Snodgrass HR: Novel B 219/OB receptor isoforms: Possible role of leptin in haematopoiesis and reproduction. Nat Med 1996;2:585-593.